Back to search

Article

Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12

2025-08-18

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Advancing age is the strongest risk factor for cardiovascular diseases (CVDs), primarily due to progressive vascular endothelial dysfunction. Cellular senescence and the senescence-associated secretory phenotype (SASP) contribute to age-related endothelial dysfunction by promoting mitochondrial oxidative stress and inflammation, which reduce nitric oxide (NO) bioavailability...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1970ce16-c3fa-5417-89df-e23c36c95077
DOI
10.1101/2025.08.13.670216
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12DOI 10.1101/2025.08.13.670216
Select a neighboring publication to make it the new centre.